A decline in vaccine confidence comes after more than a decade of hard-earned gains in routine childhood immunization. Getting back on track will be a challenging task, the agency warned.

The global trade watchdog WTO has debated through the night as it struggles to secure various deals. One country in particular has thrown a wrench in the negotiations.

US authorities determined COVID-19 vaccines should be given to children under 5, the only age group that is still ineligible for the jabs in the country.

Police have been accused of failing to keep tabs on a racist killer during one of Germany's worst-ever far-right shootings. Police say they had to proceed cautiously.

Which COVID-19 vaccines work longest? And what are their advantages and drawbacks?

A tweet claiming that Covid-19 vaccines were destroyed in Nigeria because of people power has been shown to be untrue. Vaccines were indeed trashed by the authorities, but this was due to low uptake as a result of vaccine hesitancy. We also take a look at a false claim that there are huge protests in Paris right now over pension reforms.

Coronavirus shutdowns are ending across Africa. Officials don't view severe curbs as a suitable tool for containing the spread. Vaccinations alone won't cut it. Now, Africans are seeking a way to live with the virus.

2021 began with the promise of vaccines to the rescue. But as one variant begets another, rich nations talk of boosters and jabs for kids while much of the developing world still waits for first doses.

2021 began with the promise of vaccines to the rescue. But as one variant begets another, rich nations talk of boosters and jabs for kids while much of the developing world still waits for first doses.

It's hoped that protein-based vaccines will help push the global COVID-19 vaccination program in poorer countries. Those who oppose vaccination are interested in them, too.

South Africa is grappling with the fourth wave of the coronavirus, driven by the omicron variant. The country is pushing for more vaccinations — and for its own mRNA vaccine.

The pharma giant and its German partner BioNTech announced preliminary lab results showing a 25-fold increase in protection. Germany has ordered millions of booster doses as a new government takes over in Berlin.